Loading...

Biofrontera Inc.

BFRIWNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.11
$0.02(16.91%)

Biofrontera Inc. BFRIW Peers

See (BFRIW) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
BFRIW$0.11+16.91%6.7M-0.08-$1.30N/A
ZTS$155.95-0.14%69.4B28.04$5.56+1.20%
TAK$15.46+2.38%48.6B67.17$0.23+3.81%
HLN$10.37-0.10%46.8B24.10$0.43+1.13%
TEVA$16.76+0.00%19.2B-14.56-$1.15N/A
ITCI$131.87+0.00%14B-180.64-$0.73N/A
RDY$15.03-0.27%12.5B19.26$0.78+0.64%
NBIX$125.69+0.22%12.4B42.61$2.95N/A
CTLT$63.48+0.00%11.5B-27.84-$2.28N/A
VTRS$8.93-0.89%10.5B-2.81-$3.18+5.37%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

BFRIW vs ZTS Comparison

BFRIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BFRIW stands at 6.7M. In comparison, ZTS has a market cap of 69.4B. Regarding current trading prices, BFRIW is priced at $0.11, while ZTS trades at $155.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BFRIW currently has a P/E ratio of -0.08, whereas ZTS's P/E ratio is 28.04. In terms of profitability, BFRIW's ROE is -2.16%, compared to ZTS's ROE of +0.51%. Regarding short-term risk, BFRIW is less volatile compared to ZTS. This indicates potentially lower risk in terms of short-term price fluctuations for BFRIW.

Stock Price Comparison

Loading...

Frequently Asked Questions

;